US Lawmakers Under Pressure to Enact Stricter Biosecurity Rules Following AI Industry Plea for Action

In an unprecedented show of unity, some of the world’s largest artificial intelligence companies are coming together to push US lawmakers for more stringent regulations on the development and sale of bioweapons technology. The industry leaders, who have historically been competitors in the burgeoning field of synthetic biology, are joining forces over concerns that lax biosecurity measures pose a significant threat to global health and security. By requiring companies selling synthetic DNA and RNA to screen purchases for sequences that could be used to develop biological weapons, lawmakers can help prevent the misuse of this technology and mitigate the risk of a catastrophic pandemic.